ESMO 2016: Press brief on the results from the EORTC 18071 randomized double-blind trial
Are bladder sparing procedures a real advancement in muscle invasive bladder cancer?
Expanding the clinical trial portfolio for lung cancer
Novel targets and biomarkers in mesothelioma
Live long and PROSPER: enzalutamide for nmCRPC